Pathogen and pathogenesis of amoebiasis
Amoebiasis is caused by the dysenteric amoeba (Entamoeba histolytica). In the human body and the external environment, this parasite exists in two main forms:
- Cysts: the survival stage in the external environment. This is the invasive form that ensures transmission of the infection.
- Trophozoites (vegetative forms): the active stage. They inhabit the intestinal lumen but are capable of invading the intestinal wall or migrating haematogenously to the liver.
Penetrating the intestinal wall, trophozoites cause lysis and destruction of host tissues. They multiply in the submucosa (from the surface epithelium down to the muscular layer). The pathogen is characterised by lateral spread in tissues, leading to deep ulceration and the risk of intestinal perforation. Clinically, the infection may manifest as asymptomatic carriage, invasive colitis (amoebic dysentery), or metastatic lesions (most commonly liver abscesses).
Classification of drugs by site of action
Depending on the tissues in which a drug achieves therapeutic concentration, anti-amoebic agents are divided into several groups:
- Universal amoebicides (metronidazole, ornidazole). They destroy the vegetative forms of the parasite regardless of localisation (intestine, liver, and other organs), but have absolutely no effect on cysts.
- Tissue amoebicides. They act selectively. For example, emetine (an ipecac alkaloid) works in the intestinal wall and liver, whereas chloroquine acts exclusively in the liver, making it the drug of choice in the treatment of amoebic abscesses.
- Luminal amoebicides (diloxanide). They work only in the intestinal lumen. Diloxanide is used as an insoluble ester (diloxanide furoate).
Pharmacology of metronidazole and its analogues
Metronidazole is the drug of choice for invasive forms of amoebiasis. Essentially, it is a prodrug. For it to acquire cytotoxic properties, the nitro group must be reduced inside the parasite cell. This bioactivation process is possible only in the presence of a high negative redox potential, which is characteristic of anaerobes and protozoa (microaerophiles). The reduced form of the drug binds to the amoeba's DNA, cell membranes, and proteins, causing severe cell damage and death.
Application features:
- Routes of administration: most commonly orally, but intravenous and rectal routes are also possible.
- Side effects: dyspeptic disorders, characteristic bitter metallic taste in the mouth.
- Interaction: the drug inhibits the enzyme acetaldehyde dehydrogenase. If a patient consumes alcohol during treatment, ethanol oxidation stops at the acetaldehyde stage. A disulfiram-like effect develops with severe intoxication.
A structural analogue of metronidazole is tinidazole (a second-generation nitroimidazole drug). It is also effective against a wide range of protozoa and is used for amoebiasis, giardiasis, and vaginal trichomoniasis.
Pharmacotherapy strategy
The choice of treatment regimen is always based on the clinical form of the disease and the stage of invasion:
- Acute invasive interstitial amoebiasis and liver involvement: therapy is strictly carried out in two stages. First, a systemic amoebicide (metronidazole or tinidazole) is prescribed to eradicate tissue forms. Then, a luminal amoebicide (diloxanide) must be used to eliminate residual forms of the parasite from the intestinal lumen.
- Chronic amoebiasis and asymptomatic carriage: monotherapy with a luminal agent (diloxanide) is sufficient.
Briefly: answers to topical questions
What side effects are characteristic of metronidazole?
Metronidazole is characterised by dyspeptic disorders, neurological and allergic reactions, as well as specific effects.
- Gastrointestinal disorders — dyspeptic disorders and a metallic bitter taste in the mouth.
- Neurological reactions — mentioned as part of the drug's general safety profile.
- Allergic reactions — possible during treatment.
- Disulfiram-like effect — a critically important complication associated with the inhibition of the enzyme acetaldehyde dehydrogenase. Consuming alcohol delays the oxidation of ethanol at the acetaldehyde stage, causing intoxication.
Against which anaerobic bacteria is metronidazole clinically used?
Metronidazole is used against a wide range of obligate spore-forming and non-spore-forming anaerobes. In clinical practice, the drug is used to treat infections caused by the following bacteria:
- Clostridia (Clostridium difficile) — it is a first-line drug or alternative agent in the treatment of pseudomembranous colitis and mild clostridial infection.
The drug is also active against other obligate anaerobes, although specific bacterial species are not detailed in the sources.
How does the pharmacokinetics of tinidazole differ from that of metronidazole?
The main pharmacokinetic difference between tinidazole and metronidazole lies in the duration of the half-life, which directly affects the dosing regimen when treating infections.
| Pharmacokinetic parameter | Metronidazole | Tinidazole |
|---|---|---|
| Half-life | Short | Longer |
| Application features | Requires a course of treatment (e.g., a 5-day course) | Highly effective when administered as single doses |
To remember the two-stage treatment regimen for the acute form, use the rule 'First kill in the tissues, then sweep from the lumen': Metronidazole (tissues) → Diloxanide (lumen).
Class and exam questions
Why is metronidazole not used as a single drug in intestinal amoebiasis?
It excellently destroys invasive forms in tissues, but has low efficacy against luminal amoebic forms. Therefore, for complete elimination of the pathogen, the course is always supplemented with diloxanide.
What is the danger of combining metronidazole and alcohol?
Metronidazole causes a disulfiram-like reaction. It blocks the breakdown of alcohol at the toxic acetaldehyde stage, leading to severe poisoning.
Which drug should be chosen for asymptomatic cyst carriage?
The drug of choice in this case is diloxanide, as it acts directly within the intestinal lumen.
Which forms of amoebae are unaffected by universal amoebicides?
Metronidazole and ornidazole destroy only vegetative forms (trophozoites) and have absolutely no effect on cysts.
What else to study on this topic
- Life cycle of Entamoeba histolytica and conditions for encystation
- Mechanism of development of the disulfiram-like reaction at the biochemical level
- Pharmacokinetics and spectrum of activity of tinidazole
- Features of emetine use and its toxicity
- Pathogenesis of amoebic liver abscess formation
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on 'Anti-amoebic agents' and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Drugs for protozoan infections" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.